PUBLICATIONS (2016 – 2017)
A difficult decision: Atypical JC polyomavirus encephalopathy in a kidney transplant recipient
Bialasiewicz S, Hart G, Oliver K, Agnihotri SP, Koralnik IJ, Viscidi R, Nissen MD, Sloots TP, Burke MT, Isbel NM, Burke J.
Transplantation. 2016 Jun 30
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
Schwarz E, Maukonen J, Hyytiainen T, KieseppÓ“, Oresic M, Sabunciyan S, Mantere O, Saarela M,
Yolken R, Suvisaar J.
Schizophr Res. 2017, Apr 22; S0920-9964
Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii
Kannan G, Crawford JA, Yang C, Gressitt KL, Ihenatu C, Krasnova IN, Cadet JL, Yolken RH, Severance EG, Pletnikov MV.
Association of cognitive function and liability to addition with childhood herpesvirus infections: A prospective cohort study
Vanyukov MM, Nimgaonkar VL, Kirisci L, Kirillova GP, Reynolds MD, Prasad K, Tarter RE, Yolken RH.
Dev Psychopathol. 2017 Apr 19:1-10
Association of depressed mood with Herpes Simplex Virus-2 immunoglobulin-g levels in pregnancy
Hsu PC, Yolken RH, Postolache TT, Beckie TM, Munro CL, Groer MW.
Psychosom Med. 2016 Oct;78(8):966-972
Association of DNA methylation differences with schizophrenia in an epigenome-wide association study
Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R, Idrizi A, Runarsson A, Berndsen B, Gur RC, Moore TM, Perry RT, Fugman D, Sabunciyan S, Yolken RH, Hyde TM, Kleinman JE, Sobell JL, Pato CN, Pato MT, Go RC, Nimgaonkar V, Weinberger DR, Braff D, Gur RE, Fallin MD, Feinberg AP.
JAMA Psychiatry. 2016 May 1;73(5):506-14
Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation
Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, DeLorenze GN, Kharrazi M, Yolken R, Ashwood P, Van de Water J.
Mol Psychiatry. 2017 Feb;22(2):273-279
Behavioral abnormalities in a mouse model of chronic toxoplasmosis are associated with MAG1 antibody levels and cyst burden
Xiao J, Li Y, Prandovszky E, Kannan G, Viscidi RP, Pletnikov MV, Yolken RH.
PLoS Negl Trop Dis. 2016 Apr 28;10(4):e0004674
Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder
Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CL, Ademos MB, Sweeney KM, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.
NPJ Schizophr. 2016 May 4;2:10618
Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control
Beck SE, Queen SE, Viscidi R, Johnson D, Kent SJ, Adams RJ, Tarwater PM, Mankowski JL.
J Neurovirol. 2016 Aug; 22(4):498-507
Cerebral complement C1q activation in chronic Toxoplasma infection
Xiao J, Li Y, Gressitt KL, He H, Kannan G, Schultz TL, Svezhova N, Carruthers VB, Pletnikov MV, Yolken RH, Severance EG.
Brain Behav Immun. 2016 Nov;58:52-56
CLASS2: accurate and efficient splice variant annotation from RNA-seq reads
Song L, Sabunciyan S, Florea L
Nucleic Acids Res. 2016 Jun 2:44(10):e98
Comparison of three cell-based drug screening platforms for HSV-1 infection.
D’Aiuto L, Williamson K, Dimitrion P, McNulty J, Brown CE, Dokuburra CB, Nielsen AJ, Lin WJ, Piazza P, Schurdak ME, Wood J, Yolken RH, Kinchington PR, Bloom DC, Nimgaonkar VL
Antiviral Res. 2017 Jun;142:136-140
Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders
Darby MM, Yolken RH, Sabunciyan S.
Transl Psychiatry. 2016 Sep 13;6(9):e890
Effects of cumulative Herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects
Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB.
J Clin Psychiatry. 2017 Jan;78(1):e18-e27
Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring
Allswede DM, Buka SL, Yolken RH, Torrey EF, Cannon TD
Schizophr Res. 2016 Apr;172(1-3):41-5
Enol ethers as carbonyl surrogates in a modification of the Povarov synthesis of 3-aryl quinolones and their anti-Toxoplasma activity
Brown CE, McNulty J, Bordon C, Yolken R, Jones-Brando L.
Org Biomol Chem. 2016 Jul 7;14(25):5951-5
Hepatitis C Virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample
Ibrahim I, Salah H, El Sayed H, Mansour H, Eissa A, Wood J, Fathi W, Tobar S, Gur RC, Gur RE, Dickerson F, Yolken RH, El Bahaey W, Nimgaonkar V.
J Clin Exp Neuropsychol. 2016 Oct;38(8):861-1
Human Papillomavirus (HPV) L1 serum antibodies and the risk of subsequent oral HPV acquisition in Men: The HIM Study
Pierce Campbell CM, Viscidi RP, Torres BN, Lin HY, Fulp W, Abrahamsen M, Lazcano-Ponce E, Villa LL, Kreimer AR, Giuliano AR.
J Infect Dis. 2016 Jul 1:214(1):45-8
Immuno-psychiatry: an agenda for clinical practice and innovative research
Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L.
BMC Med. 2016 Oct 28;14(1):173
Impact of serum antibodies to HPV Serotypes 6, 11, 16, and 18 to risks of subsequent genital HPV infections in men: the HIM Study
Pamnani SJ, Sudenga SL, Viscidi R, Rollison DE, Torres BN, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Huang Y, Borenstein A, Giuliano AR
Cancer Res. 2016 Oct 15;76(20):6066-6075
Individuals hospitalized with acute mania have increased exposure to antimicrobial medications
Yolken R, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Dickerson F.
Bipolar Disord. 2016 Aug;18(5):404-9
Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls
Passeri E, Jones-Brando L, Bordon C, Sengupta S, Wilson AM, Primerano A, Rapoport JL, Ishizuka K, Kano S, Yolken RH, Sawa A.
Microbes Infect. 2016 Feb;18(2):153-8
Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study
Kohler O, Petersen L, Mors O, Mortensen PB, Yolken RH, Gasse C, Benros ME.
Acta Psychiatr Scand. 2017 Feb;135(2):97-105
Infection and inflammation in schizophrenia and bipolar disorder
Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG,Yolken RH, Sawa A, Eaton WW. Neurosci Res. 2017 Feb;115:59-63
Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study
Zerbo O, Traglia M, Yoshida C, Heuer LS, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Van de Water J, Yolken RH, Weiss LA, Croen LA.
Trnsl Psychiatry. 2016 Apr 19;6:e783
Prenatal and newborn immunoglobulin levels from mother-child pairs and risk of autism spectrum disorders
Grether JK, Ashwood P, Van de Water J, Yolken RH, Anderson MC, Torres AR, Westover JB, Sweeten T, Hansen RL, Kharrazi M, Croen LA.
Front Neurosci. 2016 May 18;10:218
Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study
Severance EG, Gressitt KL, Stallings CR, Katsafanas E. Schweinfurth LA, Savage CL, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Dickerson FB, Yolken RH.
Brain Behav Immun. 2017 May;62:41-45
Race is associated with sexual behaviors and modifies the effect of age on Human Papillomavirus Serostatus among perimenopausal women
Rettig EM, Fakhry C, Rositch AF, Burke AE, Chang K, Silver MI, Viscidi R, Gravitt P.
Sex Transm Dis. 2016 Apr;43(4):231-7
Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features
Coughlin JM, Hayes LN, Tanaka T. Xiao M, Yolken RH, Worley P, Leweke FM, Sawa A.
Schizophr Res. 2016 Nov 23. S0920-9964(16)30492-3
Schizophrenia and infections: The eyes have it
Torrey EF, Yolken RH.
Schizophr Bull. 2017 Mar 1;43(2):247-252
Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer
Fakhry C, Qualliotine JR, Zhang Z, Agrawal N, Gaykalova DA, Bishop JA, Subramaniam RM, Koch WM, Chung CH, Eisele DW, Califano J, Viscidi RP.
Cancer Prev Res (Phila). 2016 Feb;9(2):135-41
Stability of Toxoplasma gondii: Antibody levels in schizophrenia
Yuksel P, Kocazeybek B, Ozdemir A, Yolken RH, Torrey EF.
Schizophr Res. 2017 Feb 27 (S0920-9964)
Suicide attempts and markers of immune response in individuals with serious mental illness
Dickerson F, Wilcox HC, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Yolken R.
J Psychiatr Res. 2017 Apr;87:37-43
The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls
Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CL, Schroeder J, Schweinfurth LA, Stallings C, Sweeney K, Yolken R.
Schizophr Res. 2016 Oct;176(2-3):566-71
The gut microbiota and the emergence of autoimmunity: Relevance to major psychiatric disorders
Severance EG, Tveiten D, Lindstrom LH, Yolken RH, Reichelt KL.
Curr Pharm Des. 2016;22(40):6076-6086
The microbiome, immunity, and schizophrenia and bipolar disorder
Dickerson F, Severance E, Yolken R.
Brain Behav Immun. 2017 May;62:46-52
Toxoplasma gondii-A gastrointestinal pathogen associated with human brain diseases
Severance EG, Xiao J, Jones-Brando L, Sabunciyan S, Li Y, Pletnikov M, Prandovszky E, Yolken R.
Int Rev Neurobiol. 2016;131:143-163
Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study
Oliveira J, Kazma R, Le Floch E, Bennabi M, Hamdani N, Bengoufa D, Dahoun M, Manier C, Bellivier F, Krishnamoorthy R, Deleuze JF, Yolken R, Leboyer M, Tamouza R.
Int J Bipolar Disorder. 2016 Dec;4(1):11
Toxoplasmosis titers and past suicide attempts among older adolescents initiating SSRI treatment
Coryell W, Yolken R, Butcher B, Burns T, Dindo L, Schlechte J, Calarge C.
Arch Suicide Res. 2016 Oct-Dec;20(4):605-13
Widespread splicing of repetitive element loci into coding regions of gene transcripts
Darby MM, Leek JT, Langmead B, Yolken RH, Sabunciyan S.
Hum Mol Genet. 2016 Nov 15;25(22):4962-4982.
NOVEL IMMUNE RESPONSE TO GLUTEN IN INDIVIDUALS WITH SCHIZOPHRENIA
TOXOPLASMA GONDII STRAIN-DEPENDENT EFFECTS ON MOUSE BEHAVIOUR
NEUROANATOMIC AND COGNITIVE ABNORMALITIES RELATED TO HERPES SIMPLEX VIRUS TYPE 1 IN SCHIZOPHRENIA
ANTIBODIES TO MEASLES IN INDIVIDUALS WIT H RECENT ONSET PSYCHOSIS
ARTEMISININ DERIVATIVES INHIBIT TOXOPLASMA GONDII IN VITRO AT MULTIPLE STEPS IN THE LYTIC CYCLE
INFECTION AND THYROID AUTOIMMUNITY: A SEROEPIDEMIOLOGIC STUDY OF TPOaAB
PATERNAL AGE AS A RISK FACTOR FOR SCHIZOPHRENIA: HOW IMPORTANT IS IT?
CORONAVIRUS IMMUNOREACTIVITY IN INDIVIDUALS WITH A RECENT ONSET OF PSYCHOTIC SYMPTOMS
A DOUBLE BLIND TRIAL OF ADJUNCTIVE ALLOPURINOL FOR SCHIZOPHRENIA
SELECTED INFECTIOUS AGENTS AND RISK OF SCHIZOPHRENIA AMONG U.S. MILITARY PERSONNEL
ARE SOME CASES OF PSYCHOSIS CAUSED BY MICROBIAL AGENTS? A REVIEW OF THE EVIDENCE
DECREASED NEUROTROPIC RESPONSE TO BIRTH HYPOXIA IN THE ETIOLOGY OF SCHIZOPHRENIA
POLYMORPHISMS IN MICB ARE ASSOCATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOHRENIA RISK
DNA METHYLATION SIGNTURES WITHIN HTE HUMAN BRAIN
MATERNAL EXPOSURE TO HERPES SIMPLEX VIRUS AND RISK OF PSYCHOSIS AMONG ADULT OFFSPRING
META-ANALYSIS OF 12 GENOMIC STUDIES IN BIPOLAR DISORDER
POLYMORPHISMS IN MICB ARE ASSOCIATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOPHRENIA RISK
POLYMORPHISMS IN THE HOMEOBOX GENE OTX2 MAY BE A RISK FACTOR FOR BIPOLR DISORDER
EARLY INFECTIONS OF TOXOPLASMA GONDII AND THE LATER DEVELOPMENT OF SCHIZOPHRENIA
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
NOVEL ALPHA7 NICOTINIC RECEPTOR ISOFORMS AND DEFICIENT CHOLINERGIC TRANSCRIPTION IN SCHIZOPHRENIA
SEROLOGICAL CROSS REACTIVITY BETWEEN POLYOMAVIRUS CAPSIDS
TEMPLE MONKEYS AND HEALTH IMPLICATIONS OF COMMENSALISM, KATHMANDU, NEPAL
PHYLOGENOMICS AND MOLECULAR EVOLUTION OF POLYOMAVIRUSES
COMPARING PHYLOGENETIC CODIVERGENCE BETWEEN POLYOMAVIRUSES AND THEIR HOSTS
TRANSACTIVATION OF ELEMENTS IN THE HUMAN ENDOGENOUS RETROVIRUS W FAMILY BY VIRAL INFECTION
EVOLUTION OF THE HUMAN IMMUNODEFICIENCY VIRUS ENVELPE GENE IS DOMINATED BY PURIFYING SELECTION
IMMUNOGLOBULIN G, A, AND M RESPONSES TO BK VIRUS IN RENAL TRANSPLANTATION
DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS
TEMPORAL TRENDS IN GONOCOCCAL POPULATION GENETICS IN A HIGH PREVALENCE URBAN COMMUNITY
INFECTIOUS AGENTS AND GENE–ENVIRONMENTAL INTERACTIONS IN THE ETIOPATHOGENESIS OF SCHIZOPHRENIA
INFECTIOUS AGENTS AND GENE–ENVIRONMENTAL INTERACTIONS IN THE ETIOPATHOGENESIS OF SCHIZOPHRENIA
IN VITRO INHIBITION OF TOXOPLASMA GONDII BY FOUR NEW DERIVATIVES OF ARTEMISININ
BRAIN MORPHOLOGICAL CHANGES ASSOCIATED WITH EXPOSURE TO HSV1 IN FIRST-EPISODE SCHIZOPHRENIA
THE LYMPHOTOXIN CYS13ARG POLYMORPHISM AND COGNITIVE FUNCTIONING IN INDIVIDUALS WITH SCHIZOPHRENIA
CYTOMEGALOVIRUSES AND SCHIZOPHRENIA
NEUROPSYCHOLOGICAL FUNCTION IN BIPOLAR DISORDER AND SCHIZPHRENIA
ANTIBODIES TO TOXOPLASMA GONDII IN PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
HSV1 EXPOSURE AFFECTS PREFRONTAL CORTICAL STRUCTURE IN SCHIZOPHRENIA PATIENTS
VIRUSES AND SCHIZOPHRENIA; A FOCUS ON HERPES SIMPLEX VIRUS
AUTISM AND HAD CIRCUMFERENCE IN THE FIRST YEAR OF LIFE
A COMPREHENSIVE GENETIC ASSOCIATION AND FUNCTIONAL STUDY OF TNF IN SCHIZOPHRENIA RISK
DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS
EVALUATING RNA STATUS FOR RT-PCR IN EXTRACTS OF POSTMORTEM HUMAN BRAIN TISSUE
ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS WITH RECENT ONSET SCHIZOPHRENIA
ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND EMPLOYMENT STATUS OF PERSONS WITH BIPOLAR DISORDER
EPIGENETIC STUDIES OF GENOMIC RETROELEMENTS IN MAJOR PSYCHOSIS
EXPRESSION OF KYNURENINE PATHWAY ENZYME TRYPTOPHAN 2
HERPESVIRUSES AND TOXOPLASMA GONDII IN ORBITAL FRONTAL CORTEX OF PSYCHIATRIC PATIENTS
INFECTION WITH HERPES SIMPLEX VIRUS TYPW 1 IS ASSOCIATED WITH COGNITIVE DEFICITS IN BIPOLAR DISORDER
LOW MATERNAL VITAMIN D AS A RISK FACTOR FOR SCHIZOPHRENIA
NO DETECTION OF PARVOVIRUS B19 OR HERPESVIRUS DNA IN GIANT CELL ARTERITIS
OLIGODENDROCYTE DYSFUNCTION IN SCHIZOPHRENIA AND BIPOLAR DISORDER
PSYCHOPATHOLOGY IN FIRST-EPISODE SCHIZOPHRENIA AND ANTIBODIES TO TOXOPLASMA GONDII